HPX and thalassemia: Hx identified peptides sequences that could be used in platforms such as nanoparticles [20] for heme-scavenging therapy, to improve the clinical outcomes for hemolytic diseases like malaria, sickle cell disease (SCD), thalassemia, and hemorrhagic conditions.